Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arecor Therapeutics PLC (DE:6UI)
FRANKFURT:6UI
Arecor Therapeutics PLC (6UI) Stock Price & Analysis
0 Followers
6UI Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€1.44 - €3.00
Previous Close€1.46
Volume0.00
Average Volume (3M)70.00
Market Cap
€45.96M
Enterprise Value€31.30M
Total Cash (Recent Filing)£12.81M
Total Debt (Recent Filing)£288.00K
Price to Earnings (P/E)N/A
Beta-0.25
Next Earnings
Apr 22, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding30,625,654
10 Day Avg. Volume0
30 Day Avg. Volume70
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)3.97
Price to Sales (P/S)18.89
Price to Cash Flow (P/CF)-4.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
6UI FAQ
What was Arecor Therapeutics PLC’s price range in the past 12 months?
Arecor Therapeutics PLC lowest stock price was €1.44 and its highest was €3.00 in the past 12 months.
What is Arecor Therapeutics PLC’s market cap?
Currently, no data Available
When is Arecor Therapeutics PLC’s upcoming earnings report date?
Arecor Therapeutics PLC’s upcoming earnings report date is Apr 22, 2024 which is in 3 days.
How were Arecor Therapeutics PLC’s earnings last quarter?
Arecor Therapeutics PLC released its earnings results on Sep 14, 2023. The company reported -€0.176 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.176.
Is Arecor Therapeutics PLC overvalued?
According to Wall Street analysts Arecor Therapeutics PLC’s price is currently Overvalued.
Does Arecor Therapeutics PLC pay dividends?
Arecor Therapeutics PLC does not currently pay dividends.
What is Arecor Therapeutics PLC’s EPS estimate?
Arecor Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Arecor Therapeutics PLC have?
Currently, no data Available
What happened to Arecor Therapeutics PLC’s price movement after its last earnings report?
Arecor Therapeutics PLC reported an EPS of -€0.176 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.952%.
Which hedge fund is a major shareholder of Arecor Therapeutics PLC?
Currently, no hedge funds are holding shares in DE:6UI
---
Arecor Therapeutics PLC Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Company Description
Arecor Therapeutics PLC
Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Arestat, it is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies.
---
Technical Analysis
Avacta Group plc
―
Arecor Therapeutics PLC
―
N4 Pharma
―
4basebio UK Societas
―
Achilles Therapeutics
―
---